Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Belimumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Belimumabmarket, defines the market attractiveness level of Belimumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Belimumab industry, describes the types of Belimumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Belimumab market and the development prospects and opportunities of Belimumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Belimumab market in Chapter 13.
By Player:
Delenex Therapeutics
AryoGen Biopharma
Tsumura
GlaxoSmithKline
Fujifilm Kyowa Kirin Biologics
Celltrion
Bionovis
MedImmune
Pfizer
Sandoz
By Type:
Injection
Powder
Lyophilized
Solution
By End-User:
Intravenous
Subcutaneous
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Belimumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Belimumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Belimumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Belimumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Belimumab Market Analysis and Outlook to 2022
-
7.1 Global Belimumab Consumption (2017-2022)
-
7.2 United States Belimumab Consumption (2017-2022)
-
7.3 Europe Belimumab Consumption (2017-2022)
-
7.4 China Belimumab Consumption (2017-2022)
-
7.5 Japan Belimumab Consumption (2017-2022)
-
7.6 India Belimumab Consumption (2017-2022)
-
7.7 South Korea Belimumab Consumption (2017-2022)
8 Region and Country-wise Belimumab Market Analysis and Outlook to 2028
-
8.1 Global Belimumab Consumption Forecast (2022-2028)
-
8.2 United States Belimumab Consumption Forecast (2022-2028)
-
8.3 Europe Belimumab Consumption Forecast (2022-2028)
-
8.4 China Belimumab Consumption Forecast (2022-2028)
-
8.5 Japan Belimumab Consumption Forecast (2022-2028)
-
8.6 India Belimumab Consumption Forecast (2022-2028)
-
8.7 South Korea Belimumab Consumption Forecast (2022-2028)
9 Global Belimumab Market Outlook by Types and Applications to 2022
-
9.1 Global Belimumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Powder Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lyophilized Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Solution Consumption and Growth Rate (2017-2022)
-
9.2 Global Belimumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Intravenous Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Subcutaneous Consumption and Growth Rate (2017-2022)
10 Global Belimumab Market Outlook by Types and Applications to 2028
-
10.1 Global Belimumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Powder Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lyophilized Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Solution Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Belimumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
11 Global Belimumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Belimumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Belimumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Belimumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Belimumab Market Competitive Analysis
-
14.1 Delenex Therapeutics
-
14.1.1 Delenex Therapeutics Company Details
-
14.1.2 Delenex Therapeutics Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Delenex Therapeutics Belimumab Product and Service
-
14.2 AryoGen Biopharma
-
14.2.1 AryoGen Biopharma Company Details
-
14.2.2 AryoGen Biopharma Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AryoGen Biopharma Belimumab Product and Service
-
14.3 Tsumura
-
14.3.1 Tsumura Company Details
-
14.3.2 Tsumura Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Tsumura Belimumab Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Belimumab Product and Service
-
14.5 Fujifilm Kyowa Kirin Biologics
-
14.5.1 Fujifilm Kyowa Kirin Biologics Company Details
-
14.5.2 Fujifilm Kyowa Kirin Biologics Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Fujifilm Kyowa Kirin Biologics Belimumab Product and Service
-
14.6 Celltrion
-
14.6.1 Celltrion Company Details
-
14.6.2 Celltrion Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Celltrion Belimumab Product and Service
-
14.7 Bionovis
-
14.7.1 Bionovis Company Details
-
14.7.2 Bionovis Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bionovis Belimumab Product and Service
-
14.8 MedImmune
-
14.8.1 MedImmune Company Details
-
14.8.2 MedImmune Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 MedImmune Belimumab Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Belimumab Product and Service
-
14.10 Sandoz
-
14.10.1 Sandoz Company Details
-
14.10.2 Sandoz Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sandoz Belimumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Belimumab
-
Figure Belimumab Picture
-
Table Global Belimumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Belimumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Belimumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Belimumab Consumption by Country (2017-2022)
-
Figure United States Belimumab Consumption and Growth Rate (2017-2022)
-
Table Europe Belimumab Consumption and Growth Rate (2017-2022)
-
Figure China Belimumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Belimumab Consumption and Growth Rate (2017-2022)
-
Figure India Belimumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Belimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Belimumab Consumption Forecast by Country (2022-2028)
-
Figure United States Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Powder Consumption and Growth Rate (2017-2022)
-
Figure Global Lyophilized Consumption and Growth Rate (2017-2022)
-
Figure Global Solution Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Powder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lyophilized Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Belimumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Belimumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Delenex Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Delenex Therapeutics Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Delenex Therapeutics Belimumab Product and Service
-
Table AryoGen Biopharma (Foundation Year, Company Profile and etc.)
-
Table AryoGen Biopharma Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table AryoGen Biopharma Belimumab Product and Service
-
Table Tsumura (Foundation Year, Company Profile and etc.)
-
Table Tsumura Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tsumura Belimumab Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Belimumab Product and Service
-
Table Fujifilm Kyowa Kirin Biologics (Foundation Year, Company Profile and etc.)
-
Table Fujifilm Kyowa Kirin Biologics Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fujifilm Kyowa Kirin Biologics Belimumab Product and Service
-
Table Celltrion (Foundation Year, Company Profile and etc.)
-
Table Celltrion Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Belimumab Product and Service
-
Table Bionovis (Foundation Year, Company Profile and etc.)
-
Table Bionovis Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bionovis Belimumab Product and Service
-
Table MedImmune (Foundation Year, Company Profile and etc.)
-
Table MedImmune Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedImmune Belimumab Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Belimumab Product and Service
-
Table Sandoz (Foundation Year, Company Profile and etc.)
-
Table Sandoz Belimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz Belimumab Product and Service
-
